SUBCATEGORY FEED

Hims & Hers Announces $49 Wegovy Copy, Novo Nordisk and Eli Lilly Tumble | Tylenol Maker Disputes FDA Proposal Linking Use During Pregnancy to Autism | VOQUEZNA® Receives 10-Year Exclusivity Extension from FDA | Hims & Hers Announces $49 Wegovy Copy, Novo Nordisk and Eli Lilly Tumble | Tylenol Maker Disputes FDA Proposal Linking Use During Pregnancy to Autism | VOQUEZNA® Receives 10-Year Exclusivity Extension from FDA

Health / Pharmaceuticals

Hims & Hers Announces $49 Wegovy Copy, Novo Nordisk and Eli Lilly Tumble

Online telehealth company Hims & Hers is set to launch a copy of the Wegovy pill for $49, significantly undercutting Novo Nordisk’s $149 branded version. This announcement has sent shockwaves through the pharmaceutical market, impacting the...

Image via Bloomberg.com

Feb 05, 2026 15:02 Novo Shares Fall As Hims & Hers Offers $49 Wegovy Copycat

Health / Pharmaceuticals

Tylenol Maker Disputes FDA Proposal Linking Use During Pregnancy to Autism

Oct 21, 2025 14:31 Tylenol’s maker pushes back against possible label change linking pain reliever’s use in pregnancy to autism

Health / Pharmaceuticals

VOQUEZNA® Receives 10-Year Exclusivity Extension from FDA

Jun 06, 2025 17:01 Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

Vaccines Infectious Diseases Public Health Weight Loss Wellness Cancer Nutrition Policy Mental Health Fitness